hereditary

BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)

BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)

April 28, 2025 04:00 ET  | Source: BlackfinBio CHESHIRE, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- BlackfinBio Ltd, a…

3 weeks ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary RiskCancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk

National Comprehensive Cancer Network overhauls two major resources to help cancer care providers and other stakeholders stay current on cutting…

6 months ago